期刊文献+

微量蛋白尿与缺血性脑卒中的相关危险因素分析

Analysis of the Correlative Risk Factors Between Microalbuminuria and Ischemic Stroke
下载PDF
导出
摘要 目的探讨微量蛋白尿与急性初发缺血性脑卒中的相关危险因素。方法将所有患者分为病例组(急性初发缺血性脑卒中患者84例)与对照组(非缺血性脑卒中患者62例),比较两组微量蛋白尿阳性率及绝对值,用Logistic回归分析其是否为具有与高血压病,糖代谢紊乱,吸烟等传统缺血性卒中危险因素同等地位的独立危险因素。结果急性初发缺血性脑卒中组微量蛋白尿阳性率明显高于非卒中组,差异有统计学意义,微量蛋白尿与吸烟,高血压病,性别等同为脑梗塞发生的危险因素,OR值分别为8.163,4.979,9.196,2.720。结论微量蛋白尿是急性初发缺血性脑卒中的独立危险因素,可作为潜在的治疗靶点。 Objective To Discuss the correlative risk factors between microalbuminuria and the acutely incipient ischemic stroke. Methods Comparing the positive rate and absolute value of microalbuminuria of the two groups, in which the case group contains 84 acute and incipient ischemic stroke patients, while the control group 62 non-ischemic stroke patients. Analysing it with logistic regression model, to find whether the micro-albuminuria is an independent risk factor of ischemic stroke, like the tranditional ones of hypertension, glycometabolic disorder and smoking. Results The positive rate of microalbuminuria in acute and incipient ischemic stroke group is much higher than that in the other group, the difference is statistically meaningful. Microalbuminuria, smoking, hypertension and sex are independent risk factors of ischemic stroke, and the OR values are 8.163, 4.979, 9.196 and 2.720 respectively. Conclusion Microalbuminuria is an independent risk factor of acutely incipient ischemic stroke, which can be used as a potential therapeutic target.
出处 《中外医疗》 2013年第36期3-4,共2页 China & Foreign Medical Treatment
关键词 微量蛋白尿 缺血性脑卒中 危险因素 Microalbuminuria Ischemic stroke Risk factor
  • 相关文献

参考文献6

二级参考文献44

  • 1黄惠玲,孙东升,黄慧芳.老年高血压人群血HCY、尿MAU测定及其临床意义[J].浙江医学,2005,27(3):171-172. 被引量:2
  • 2Munakata M, Nunokawa T, Yoshinaga K, et al. Brachial ankle pulse wave velocity is an independent risk factor for microalbuminuria in patients with essential hypertension: a Japanese trial on the prognostic implication of pulse wave velocity (J-TOPP)[J]. Hypertens Res,2006,29(7) :515-521.
  • 3Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study[J]. Kidney Int,2006,70(4) : 751-756.
  • 4Rosenbaum P, Gimeno S G, Sanudo A, et al. Independent impact of glycemia and blood pressure in albuminuria on high risk subjects for metabolic syndrome[J]. Clin Nephrol,2004,61 (6):369-376.
  • 5Kvenild K, Romundstad S, Midthjell K, et al. Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk? The HUNT Study, Norway[J]. Scand J Prim Heath Care, 2006,24(3):145-153.
  • 6Juhan W, Anand V. The problem of diabetic nepropathy and practi- cal prevention of its progression[ J]. The Journal of Diabetes& Vas- cular Disease ,208,8:272 - 277.
  • 7Parijat D, Gautam D, karen H, et al. Dual blockade of rennin - an- gle tensin system in diabetic nephropathy: review of literature and local expeience[ J]. The British Journal of Diabetes&Vasculae Dis- case ,2006,6:23 - 28.
  • 8Wu AY, Kong NC, De Leon FA, et al. An alarmingly high pre- nalence of diabetic nepbropathy in Asian type 2 diabetic patients : The Microalbuminuri Prevalenc ( MAP ) Study [ J ]. Diabetologia, 2005,48 ( 1 ) : 17 - 26.
  • 9Cirillo M, Stellato D, Lombardi C, et al. Urinary albumin excretion and coronary artery disease. G Ital Nefrol, 2006, 23 Suppl 34:S11-15.
  • 10de Zeeuw D. Albuminuria, just a marker for cardiovascular disease, or is it more? J Am Soc Nephrol,2005,16: 1883-1885.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部